VenoStent is biomaterials company developing bioresorbable, smart polymers to transform vascular surgery.
VenoStent is a clinical-stage tissue engineering company that’s developed tunable, bioabsorbable smart polymer wraps in order to fundamentally transform the 5 million vascular surgeries performed each year.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 23, 2021 | Seed | $3M | 8 | Creative Ventures | — | Detail |
Aug 25, 2020 | Seed | $150K | 1 | Y Combinator | — | Detail |
Jul 10, 2020 | Grant | $500K | 1 | — | — | Detail |
Apr 26, 2020 | Seed | $535K | 2 | — | — | Detail |
Oct 2, 2019 | Non-Equity Assistant | — | 1 | MassChallenge | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Creative Ventures | Yes | Seed |
Y Combinator | Yes | Seed |
MassChallenge | Yes | Non-Equity Assistant |
National Science Foundation | Yes | Grant |
C3 Ventures | — | Seed |
Cowtown Angels | — | Seed |
IAG Capital Partners | — | Seed |
Kube VC | — | Seed |
Olima Ventures | — | Seed |
SP Investment Fund | — | Seed |